We are currently working hard on finalizing the programme for this unique and substantial symposium. Below you’ll find what to expect. More information on the programme and participating experts will be added in the coming weeks.
Welcome
By Henri Lenferink, Mayor of the city of Leiden and Annetje Ottow, President of the Executive Board of Leiden University
Special video message
By Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization
Introduction of the Leiden LSH ecosystem
By Prof Pancras Hogendoorn, vice-chair of the executive board LUMC and dean of the Leiden University Faculty of Medicine, and Ida Haisma, director Foundation Leiden Bio Science Park (LBSP).
Brief introduction of the Leiden/LBSP ecosystem and Q&A with Anne Kerber, Senior Vice President and Head of Cell Therapy Development Bristol Myers Squibb regarding their new cell therapy facility which will open in Leiden in 2024.
Opening Speeches
African – European Collaboration in Health with focus on vaccine production and health data sharing, by Hon. Chief Fortune Charumbira, Acting President of the Pan African Parliament
Efforts by Dutch Ministry of Foreign Affairs towards a global health agenda in collaboration with the Ministry of Health, by the Minister of Foreign Trade & Development Cooperation of the Netherlands (to be confirmed)
Q&A with Mr. Bill Gates on his new book: How to Prevent the Next Pandemic (to be confirmed)
Speech ‘Towards a global health architecture’
By Mr. Budi Gunadi Sadikin, Minister of Health of Indonesia
Speech on the importance of structured efforts towards global collaboration in science & innovation in relation to health
By Dario C. Altieri, Director of The Wistar Institute Cancer Center
High-level fireside chat
Between Director General of the Food and Drug Authority of Rwanda, Emile Bienvenu (confirmed) and Hans Schikan (confirmed), Topteam Member Dutch Topsector Life Sciences & Health
Rwanda is one of the frontrunners in developments on African regional manufacturing hubs. Emile Bienvenu will discuss his observations and recommendations on Pandemic Preparedness in a global context with Hans Schikan. Schikan brings more than 30 years’ experience in the (bio)pharmaceutical sector and will deliberate on his experience as former Special Envoy Vaccines, appointed by the Dutch Ministry of Health.
Keynote Diversity in clinical trials
By Anne Kerber, Senior Vice President, Head of Cell Therapy Development, Bristol Myers Squibb